Figure S3 from First-in-Human Study of ABY-029, a Novel Fluorescent Peptide that Targets EGFR, Applied to Soft-Tissue Sarcomas

Figure S3 from First-in-Human Study of ABY-029, a Novel Fluorescent Peptide that Targets EGFR, Applied to Soft-Tissue Sarcomas

<p>Supplemental figure correlating biological variance ratio (BVR) to contrast-to-variance ratio (CVR).</p>

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Kimberley S. Samkoe (20877828) (author)
مؤلفون آخرون: Hira Shahzad Sardar (21233329) (author), Jason R. Gunn (21233332) (author), Jonathan Thomas Elliott (21233335) (author), Sally Mansur (21233338) (author), Joachim Feldwisch (21233341) (author), Brian W. Pogue (17534777) (author), Konstantinos Linos (21233344) (author), Keith D. Paulsen (17534780) (author), Eric R. Henderson (21233347) (author)
منشور في: 2025
الموضوعات:
Cancer
Cancer Detection and Diagnosis
Therapeutic Research and Development
Clinical Research and Trials
Methods and Technology
Biological Agents & Therapies
Antireceptors
Clinical Imaging
Clinical Trial Results
Engineering
Imaging
Imaging probes
Sarcomas
Soft-tissue sarcoma
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
كن أول من يترك تعليقا!
يجب تسجيل دخولك أولا

مواد مشابهة